阿茲海默症是一種普遍的、隨著時間惡化的人類神經退化性疾病，其主要病徵是因腦中不正常的β澱粉樣蛋白(Aβ)聚集堆積所導致。人們對Aβ致病性的肇因尚不清楚。在過去的幾年中，基於阿茲海默症的Aβ假說而設計的,幾種被認為非常有潛力的抗失智症藥物，包括四種用抗體結合Aβ以防止其聚集的藥物，皆在藥物試驗後期階段失敗。在藥物抗體策略中的研究假設是減少Aβ在細胞間隙中繼續累積。我們使用全基因體的基因表達數據 (取自正常老化腦組織和阿茲海默症病人死後大腦樣本)，與過去許多發現完全吻合，提及兩點作為討論: (1) 阿茲海默症致病基因與癌症之間呈現反向表現關係; (2) 微生物感染可能與阿茲海默症有關。我們最重要的推測是蛋白體酶和氧化磷酸化可能是阿茲海默症病患中受損最嚴重的兩個功能;這個狀況在病人大腦的海馬迴和後扣帶回區域最明顯。我們的研究結果顯示在阿茲海默症五個腦區的差異以及與老化的關連性，並推論出可能的標靶基因。這些結果可能有助於應用於阿茲海默症的診斷和治療。;Alzheimer′s disease (AD) is a prevalent progressive neurodegenerative human disease. Several initially highly hopeful anti-AD drugs based on the amyloid-β (Aβ) hypothesis of AD have failed recent late-phase tests, and the cause of AD remains unclear. Natural aging (AG) is a high risk factor for AD. Here, five sets of gene expression microarray data from different regions of AD affected brain, and one of AG, were analyzed for identifying putatively disrupted biological pathways or functions and their abnormal molecular contents. Brain-region specificity among AD cases and AG-AD differences in KEGG-termed function disruption were identified. AG was significantly more at risk to cancer than was AD; hippocampus, the region with the strongest AD signatures, showed no risk to cancer. Our results also showed that microbial related KEGG terms were enriched in five AD affected brain regions, especially in E. coli infection Pathway. Oxidative phosphorylation (OXPHOS; Fisher’s exact test p=1.1E-20) and proteasome (p=2.0E-18) were found to be the most putatively disrupted functions and 24 new target genes were identified. Our results highlighted the heterogeneity of AD in the five brain regions, and indicated a possible AG-AD connection. These may be useful in devising strategies for the early detection of AD. Based on our results we comment on a number of recent late-phase failures of anti-AD drug trials.